Company Filing History:
Years Active: 2025
Title: Adam Daniel Judge: Innovator in Cancer Therapy
Introduction
Adam Daniel Judge is a notable inventor based in Bainbridge Island, WA (US). He has made significant contributions to the field of cancer therapy through his innovative work. His expertise and dedication to research have led to the development of groundbreaking technologies.
Latest Patents
Adam holds a patent for a polypeptide comprising a single-domain antibody variable region that binds delta-like ligand 3 (DLL3) and method of use thereof to make a radionuclide complex. This patent describes heavy chain antibodies that bind to DLL3 and immunoconjugates of DLL3 heavy chain antibodies, which are useful for cancer therapy. His work in this area is crucial for advancing treatment options for patients.
Career Highlights
Adam is currently associated with Abdera Therapeutics Inc., where he continues to push the boundaries of cancer research. His role at the company allows him to collaborate with other talented professionals in the field.
Collaborations
Some of his coworkers include Michael J Abrams and Emma Jane Cummins, who contribute to the innovative environment at Abdera Therapeutics Inc. Their collective efforts are aimed at enhancing cancer treatment methodologies.
Conclusion
Adam Daniel Judge's contributions to cancer therapy through his patent and work at Abdera Therapeutics Inc. highlight his commitment to innovation in the medical field. His research is paving the way for new therapeutic approaches that could significantly impact patient care.